Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies - Revenue Recognition (Details)

v3.23.1
Significant Accounting Policies - Revenue Recognition (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Disaggregation of Revenue    
Total Revenue $ 302,077 $ 273,544
Revenue | Product Concentration Risk    
Disaggregation of Revenue    
Percentage of total revenue (as a percent) 100.00% 100.00%
Capitated revenue    
Disaggregation of Revenue    
Total Revenue $ 298,704 $ 269,685
Capitated revenue | Revenue | Product Concentration Risk    
Disaggregation of Revenue    
Percentage of total revenue (as a percent) 98.90% 98.60%
Clinic fees and insurance    
Disaggregation of Revenue    
Total Revenue $ 1,480 $ 1,882
Clinic fees and insurance | Revenue | Product Concentration Risk    
Disaggregation of Revenue    
Percentage of total revenue (as a percent) 0.50% 0.70%
Care coordination / management fees    
Disaggregation of Revenue    
Total Revenue $ 1,850 $ 1,921
Care coordination / management fees | Revenue | Product Concentration Risk    
Disaggregation of Revenue    
Percentage of total revenue (as a percent) 0.60% 0.70%
Incentive fees    
Disaggregation of Revenue    
Total Revenue $ 43 $ 56
Incentive fees | Revenue | Product Concentration Risk    
Disaggregation of Revenue    
Percentage of total revenue (as a percent) 0.00% 0.00%
Total other patient service revenue    
Disaggregation of Revenue    
Total Revenue $ 3,373 $ 3,859
Total other patient service revenue | Revenue | Product Concentration Risk    
Disaggregation of Revenue    
Percentage of total revenue (as a percent) 1.10% 1.40%